Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

UK MIDDAY BRIEFING: GlaxoSmithKline Investigates Iraq Allegations

7th Apr 2014 11:40

LONDON (Alliance News) - Pharmaceuticals giant <strong>GlaxoSmithKline</strong> has confirmed that is investigating allegations of improper conduct in its Iraq business.<br /><br />The Wall Street Journal had cited a person familiar with the matter saying that Glaxo was violating US and UK ant Read More

GlaxoSmithKline Confirms Investigations Into Iraq Business

7th Apr 2014 10:53

LONDON (Alliance News) - GlaxoSmithKline PLC is investigating allegations of improper conduct in its Iraq business, a spokesperson for the company confirmed Monday. "We have zero tolerance for unethical or illegal behaviour," the spokesperson said in a statement. The spokesperson note Read More

TOP NEWS: Glaxo Investigating Its Conduct In Iraq - Reports

7th Apr 2014 10:06

LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />British drugmaker<strong> GlaxoSmithKline</strong> PLC is investigating claims of improper conduct related to its business in Iraq, less than a y Read More

UK MORNING BRIEFING: Shares Led Lower; Kentz Receives Contract

7th Apr 2014 07:38

LONDON (Alliance News) - Weak leads from the US and Asia have combined with continued tensions in the Ukraine to depress UK shares at the open Monday.<br /><br />Among UK corporate news at the start of the week, <strong>Kentz</strong> said it has been awarded a USD570 million services contract Read More

PRESS: Glaxo Investigating Claims Of Improper Conduct In Iraq - New York Times

7th Apr 2014 06:42

LONDON (Alliance News) - British drugmaker GlaxoSmithKline is investigating claims of improper conduct related to its business in Iraq, less than a year after China accused Glaxo of engaging in a bribery scheme aimed at increasing drug sales there, the New York Times reports. The Wall Stree Read More

UK Dividends Calendar - Week Ahead

7th Apr 2014 05:28

Read More

UK Dividends Calendar - Week Ahead

4th Apr 2014 15:00

Read More

Glaxo Withholding Some China Incentive Payments Following Probe

4th Apr 2014 14:14

LONDON (Alliance News) - GlaxoSmithKline PLC has sometimes withheld incentive payments to staff in China when it has found potential issues with expenses claims, and has increased its monitoring and checking of claims in the country following bribery investigations by Chinese authorities, a spoke Read More

UK MIDDAY BRIEFING: EasyJet, Flybe Passenger Numbers Soar

4th Apr 2014 11:33

LONDON (Alliance News) - Airlines are trading higher Friday after low-cost airlines easyJet and Flybe Group said they flew more passengers and filled more of the seats in their planes in recent weeks. <br /><br /><strong>EasyJet</strong> said it flew 5.1 million passengers in March, up from ne Read More

TOP NEWS: easyJet And Flybe Fly More Passengers But Not Aer Lingus

4th Apr 2014 10:22

LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />Low-cost airlines <strong>easyJet</strong> PLC and <strong>Flybe</strong> Group PLC said they flew more passengers and filled more of the seats i Read More

PRESS: GlaxoSmithKline Cuts Jobs In China - WSJ

4th Apr 2014 10:06

LONDON (dpa-AFX) - GlaxoSmithKline PLC. is reducing its employees in China, the Wall Street Journal reported citing a person familiar with the matter, as the company grapples with Beijing's accusations that it bribed doctors and officials to boost sales. Quoting the person, the Journal said Read More

UK Dividends Calendar - Week Ahead

4th Apr 2014 05:32

Read More

UK MIDDAY BRIEFING: Marks & Spencer Unveils Global Growth Plan

2nd Apr 2014 11:57

LONDON (Alliance News) - <strong>Marks and Spencer</strong> Group PLC is planning to open 250 new stores outside the UK over the next three years, as part of its global expansion plans.<br /><br />M&amp;S currently operates a total of 455 stores in 53 territories outside the UK, as well as nin Read More

DIRECTOR DEALINGS: Glaxo Non-Executives Awarded Shares, ADSs

2nd Apr 2014 11:30

LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a group of non-executives was awarded shares and American Depositary Shares at GBP16.08 per share and USD53.75 each respectively Monday.<br /><br />Details are as follows.<br /><br /> <table class="ae" style="width: 400px; height: Read More

UK WINNERS & LOSERS: Marks & Spencer Rises On Expansion Plans

2nd Apr 2014 10:47

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br /><br />-------<br /><br />FTSE 100 - WINNERS<br /><br /><strong>Marks and Spencer</strong> Group, up 2.4%. The retailer has announced that it is planning to ope Read More

TOP NEWS: BP To Shutter Oil Refinery In Brisbane, Australia

2nd Apr 2014 10:27

LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br /><strong>COMPANIES</strong><br />---------- <strong>BP</strong> PLC announced it intends to halt refinery operations at its major Bulwer Island refinery in Brisbane, Australia by mid-20 Read More

UK MORNING BRIEFING: FirstGroup In Line; Go-Ahead Tipped By Goldman

2nd Apr 2014 07:38

LONDON (Alliance News) - Shares have opened flat to slightly down Wednesday, despite a record close in the US and strong UK house price data.<br /><br />Goldman Sachs has added <strong>Go-Ahead</strong> Group to its Conviction Buy List with a price target of 2,310 pence. The bus and train comp Read More

Glaxo Stops MAGE-A3 Cancer Treatment Phase III Trial

2nd Apr 2014 07:04

LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had chosen to stop the Phase III trial of its MAGE-A3 cancer immunotherapeutic in non-small cell lung cancer patients, as it said it would not be possible to identify a sub-population of MAGE-A3 positive patients with a specific gene Read More

UK MIDDAY BRIEFING: Weir Group Leads Flurry Of M&A Activity

1st Apr 2014 12:05

LONDON (Alliance News) - <strong>Weir Group</strong>'s takeover approach to Finnish rival Metso is the biggest of a flurry of deals and potential deals announced Tuesday, with <strong>GKN</strong> acquiring the William's Formula 1 team parent's hybrid engine unit and <strong>Capita</strong> bo Read More

Glaxo Study Shows Patients Prefer Its Votrient Treatment

1st Apr 2014 11:13

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday a Phase III study of patients with advanced renal cell carcinoma showed that 70% of patients preferred Glaxo's Votrient treatment to Sutent, which is owned by CP Pharmaceuticals International C.V. CP Pharmaceuticals is comprised of Read More

FTSE 100 Latest
Value8,735.60
Change16.85